Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Sytl2em1/Cya
Common Name:
Sytl2-KO
Product ID:
S-KO-17803
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Sytl2-KO
Strain ID
KOCMP-83671-Sytl2-B6J-VB
Gene Name
Sytl2
Product ID
S-KO-17803
Gene Alias
Slp2; mKIAA1597
Background
C57BL/6JCya
NCBI ID
83671
Modification
Conventional knockout
Chromosome
7
Phenotype
MGI:1933366
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Sytl2em1/Cya mice (Catalog S-KO-17803) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000190731
NCBI RefSeq
NM_001289583
Target Region
Exon 12~13
Size of Effective Region
~2.7 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Sytl2, or synaptotagmin-like 2, has been implicated in multiple biological processes and disease-related pathways. Although its exact essential function is still being elucidated, it has connections to cell migration, invasion, and immune-related processes. In cell migration, it may be involved in cytoskeletal-related mechanisms, and in the immune context, it could potentially play a role in immune cell regulation and function [1,2,7].

In prostate cancer, SYTL2 promotes metastasis by enhancing FSCN1-mediated pseudopodia formation and invasion. It binds to and inhibits the proteasome degradation pathway of FSCN1, increasing its stability and leading to enhanced cell migration, invasion, and lymph node metastasis both in vitro and in vivo [1].

In thoracic aortic aneurysm, SYTL2, along with COL1A1, may be diagnostic marker genes. Their upregulation might be involved in inflammatory infiltration of the vessel wall and poor extracellular matrix remodeling, promoting the disease progression [2].

In spinal osteosarcoma, SYTL2 is part of the miR-654-3p/SYTL2 axis targeted by lncRNA BSN-AS2, which promotes cancer progression [3].

In ovarian cancer, overexpression of SYTL2 promotes metastatic potential, including increased migration and invasiveness [4].

In alveolar soft-part sarcoma, Sytl2 is involved in the intracellular trafficking of bioactive signals during angiogenesis [5,6]. Additionally, SYTL2 has been identified as a potential diagnostic biomarker for sleep-deprivation related myocardial infarction, and is strongly associated with resting NK cells and NK cell signaling pathways [7].

In conclusion, Sytl2 plays crucial roles in cancer metastasis, disease diagnosis, and potentially in immune-related diseases. Studies on Sytl2, especially through in vivo models in cancer research, have provided valuable insights into its functions in promoting cancer cell migration and invasion, as well as its potential as a diagnostic biomarker in non-cancerous diseases. This knowledge can contribute to the development of new therapeutic strategies and diagnostic methods for related diseases.

References:
1. Li, Zean, Tao, Yiran, Gao, Ze, Chen, Xu, Huang, Hai. 2023. SYTL2 promotes metastasis of prostate cancer cells by enhancing FSCN1-mediated pseudopodia formation and invasion. In Journal of translational medicine, 21, 303. doi:10.1186/s12967-023-04146-y. https://pubmed.ncbi.nlm.nih.gov/37147713/
2. Xie, Xinsheng, Yuan, Ye, Huang, Yulong, Fu, Weiguo, Wang, Lixin. 2023. Effects of COL1A1 and SYTL2 on inflammatory cell infiltration and poor extracellular matrix remodeling of the vascular wall in thoracic aortic aneurysm. In Chinese medical journal, 137, 1105-1114. doi:10.1097/CM9.0000000000002808. https://pubmed.ncbi.nlm.nih.gov/37640670/
3. Zhou, Xianwei, Li, Jitian, Teng, Junyan, Liu, Linyun, Zhang, Wenming. 2020. Long noncoding RNA BSN-AS2 induced by E2F1 promotes spinal osteosarcoma progression by targeting miR-654-3p/SYTL2 axis. In Cancer cell international, 20, 133. doi:10.1186/s12935-020-01205-y. https://pubmed.ncbi.nlm.nih.gov/32351327/
4. Sung, Hye Youn, Han, Jihye, Ju, Woong, Ahn, Jung-Hyuck. 2016. Synaptotagmin-like protein 2 gene promotes the metastatic potential in ovarian cancer. In Oncology reports, 36, 535-41. doi:10.3892/or.2016.4835. https://pubmed.ncbi.nlm.nih.gov/27220283/
5. Chuaychob, Surachada, Lyu, Ruyin, Tanaka, Miwa, Nakamura, Takuro, Yokokawa, Ryuji. 2024. Mimicking angiogenic microenvironment of alveolar soft-part sarcoma in a microfluidic coculture vasculature chip. In Proceedings of the National Academy of Sciences of the United States of America, 121, e2312472121. doi:10.1073/pnas.2312472121. https://pubmed.ncbi.nlm.nih.gov/38502703/
6. Tanaka, Miwa, Chuaychob, Surachada, Homme, Mizuki, Yokokawa, Ryuji, Nakamura, Takuro. 2023. ASPSCR1::TFE3 orchestrates the angiogenic program of alveolar soft part sarcoma. In Nature communications, 14, 1957. doi:10.1038/s41467-023-37049-z. https://pubmed.ncbi.nlm.nih.gov/37029109/
7. Chen, Xiang, Li, Qian, Zhang, Zhong, Yang, Minjing, Wang, E. 2022. Identification of Potential Diagnostic Biomarkers From Circulating Cells During the Course of Sleep Deprivation-Related Myocardial Infarction Based on Bioinformatics Analyses. In Frontiers in cardiovascular medicine, 9, 843426. doi:10.3389/fcvm.2022.843426. https://pubmed.ncbi.nlm.nih.gov/35369343/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest